Polyethylene glycol 400 1 % / tetrahydrozoline HCl 0.05 % Ophthalmic Solution
RxNorm 996209
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 996209 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: polyethylene glycol 400 1 % / tetrahydrozoline HCl 0.05 % Ophthalmic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Polyethylene glycol 400 10 mg/ML / tetrahydrozoline hydrochloride 0.5 mg/ML Ophthalmic Solution
(Atom ID: 12344011)
SYPrescribable
Synonym (SY):
PEG 400 1 % / tetrahydrozoline hydrochloride 0.05 % Ophthalmic Solution
(Atom ID: 3272532)
PSNPrescribable
Prescribable Name (PSN):
Polyethylene glycol 400 1 % / tetrahydrozoline HCl 0.05 % Ophthalmic Solution
(Atom ID: 6403619)
Patient Education
Tetrahydrozoline Ophthalmic
Ophthalmic tetrahydrozoline is used to relieve minor eye irritation and redness caused by colds, pollen, and swimming.
[Learn More]
* Please review the disclaimer below.